Neuropsychopharmacology - Table of Contents alert Volume 42 Issue 1

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 42, Issue 1 (January 2017) In this issue Editorial Review Articles Hot Topics Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Editorial Top The Immunology of Behavior—Exploring the Role of the Immune System in Brain Health and Illness Andrew H Miller, Ebrahim Haroon and Jennifer C Felger Neuropsychopharmacology 2017 42: 1-4; 10.1038/npp.2016.229 Full Text Review Articles Top Pathogen–Host Defense in the Evolution of Depression: Insights into Epidemiology, Genetics, Bioregional Differences and Female Preponderance Charles L Raison and Andrew H Miller Neuropsychopharmacology 2017 42: 5-27; advance online publication, September 15, 2016; 10.1038/npp.2016.194 Abstract | Full Text Central Nervous System: (Immunological) Ivory Tower or Not? Ioana A Marin and Jonathan Kipnis Neuropsychopharmacology 2017 42: 28-35; advance online publication, July 11, 2016; 10.1038/npp.2016.122 Abstract | Full Text Danger Signals and Inflammasomes: Stress-Evoked Sterile Inflammation in Mood Disorders Monika Fleshner, Matthew Frank and Steven F Maier Neuropsychopharmacology 2017 42: 36-45; advance online publication, July 14, 2016; 10.1038/npp.2016.125 Abstract | Full Text Repeated Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the Signal Michael D Weber, Jonathan P Godbout and John F Sheridan Neuropsychopharmacology 2017 42: 46-61; advance online publication, June 20, 2016; 10.1038/npp.2016.102 Abstract | Full Text Immune and Neuroendocrine Mechanisms of Stress Vulnerability and Resilience Caroline Ménard, Madeline L Pfau, Georgia E Hodes and Scott J Russo Neuropsychopharmacology 2017 42: 62-80; advance online publication, June 13, 2016; 10.1038/npp.2016.90 Abstract | Full Text Genetic Contributions of Inflammation to Depression OPEN Jacob Barnes, Valeria Mondelli and Carmine M Pariante Neuropsychopharmacology 2017 42: 81-98; advance online publication, August 24, 2016; 10.1038/npp.2016.169 Abstract | Full Text Psychoneuroimmunology of Early-Life Stress: The Hidden Wounds of Childhood Trauma? Andrea Danese and Stephanie J Lewis Neuropsychopharmacology 2017 42: 99-114; advance online publication, September 15, 2016; 10.1038/npp.2016.198 Abstract | Full Text Role of Adiposity-Driven Inflammation in Depressive Morbidity Lucile Capuron, Julie Lasselin and Nathalie Castanon Neuropsychopharmacology 2017 42: 115-128; advance online publication, July 11, 2016; 10.1038/npp.2016.123 Abstract | Full Text Sleep Health: Reciprocal Regulation of Sleep and Innate Immunity Michael R Irwin and Mark R Opp Neuropsychopharmacology 2017 42: 129-155; advance online publication, August 11, 2016; 10.1038/npp.2016.148 Abstract | Full Text Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse Michael J Lacagnina, Phillip D Rivera and Staci D Bilbo Neuropsychopharmacology 2017 42: 156-177; advance online publication, July 11, 2016; 10.1038/npp.2016.121 Abstract | Full Text Microbes, Immunity, and Behavior: Psychoneuroimmunology Meets the Microbiome Timothy G Dinan and John F Cryan Neuropsychopharmacology 2017 42: 178-192; advance online publication, June 20, 2016; 10.1038/npp.2016.103 Abstract | Full Text Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders Ebrahim Haroon, Andrew H Miller and Gerard Sanacora Neuropsychopharmacology 2017 42: 193-215; advance online publication, September 15, 2016; 10.1038/npp.2016.199 Abstract | Full Text Inflammation Effects on Motivation and Motor Activity: Role of Dopamine Jennifer C Felger and Michael T Treadway Neuropsychopharmacology 2017 42: 216-241; advance online publication, August 2, 2016; 10.1038/npp.2016.143 Abstract | Full Text In Sickness and in Health: The Co-Regulation of Inflammation and Social Behavior Naomi I Eisenberger, Mona Moieni, Tristen K Inagaki, Keely A Muscatell and Michael R Irwin Neuropsychopharmacology 2017 42: 242-253; advance online publication, August 2, 2016; 10.1038/npp.2016.141 Abstract | Full Text Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond Vasiliki Michopoulos, Abigail Powers, Charles F Gillespie, Kerry J Ressler and Tanja Jovanovic Neuropsychopharmacology 2017 42: 254-270; advance online publication, August 11, 2016; 10.1038/npp.2016.146 Abstract | Full Text Role of Inflammation in Suicide: From Mechanisms to Treatment Lena Brundin, Elena Y Bryleva and Keerthi Thirtamara Rajamani Neuropsychopharmacology 2017 42: 271-283; advance online publication, July 5, 2016; 10.1038/npp.2016.116 Abstract | Full Text The Role of the Immune System in Autism Spectrum Disorder Amory Meltzer and Judy Van de Water Neuropsychopharmacology 2017 42: 284-298; advance online publication, August 18, 2016; 10.1038/npp.2016.158 Abstract | Full Text Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions Brian J Miller and David R Goldsmith Neuropsychopharmacology 2017 42: 299-317; advance online publication, September 22, 2016; 10.1038/npp.2016.211 Abstract | Full Text Microglia Priming with Aging and Stress Anzela Niraula, John F Sheridan and Jonathan P Godbout Neuropsychopharmacology 2017 42: 318-333; advance online publication, September 8, 2016; 10.1038/npp.2016.185 Abstract | Full Text Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation Andrew H Miller, Ebrahim Haroon and Jennifer C Felger Neuropsychopharmacology 2017 42: 334-359; advance online publication, August 24, 2016; 10.1038/npp.2016.167 Abstract | Full Text Hot Topics Top Dissecting Suicidality Using a Combined Genomic and Clinical Approach Alexander B Niculescu and Helen Le-Niculescu Neuropsychopharmacology 2017 42: 360; 10.1038/npp.2016.228 Full Text Food Addiction and Obesity Carrie R Ferrario Neuropsychopharmacology 2017 42: 361; 10.1038/npp.2016.221 Full Text The Emerging Role of Innate Immunity in Alzheimer’s Disease Deepak Kumar Vijaya Kumar and Robert D Moir Neuropsychopharmacology 2017 42: 362; 10.1038/npp.2016.226 Full Text Pramipexole in Treatment Resistant-Depression, Possible Role of Inflammatory Cytokines Rodrigo Escalona and Jan Fawcett Neuropsychopharmacology 2017 42: 363; 10.1038/npp.2016.217 Full Text Modeling the Impact of Social Contact on Substance Use Mark A Smith and Justin C Strickland Neuropsychopharmacology 2017 42: 364; 10.1038/npp.2016.218 Full Text Impact on Cortical Function of Cocaine Abuse Co-Occurring with HIV T Celeste Napier Neuropsychopharmacology 2017 42: 365; 10.1038/npp.2016.222 Full Text Mirror Neurons in Psychiatric Disorders: from Neuroception to Bio-behavioral System Dysregulation Amedeo Minichino and Kristin Cadenhead Neuropsychopharmacology 2017 42: 366; 10.1038/npp.2016.220 Full Text The Cannabinoid Receptor 1 as a Key Mediator of Adolescent Behavior Rainer Spanagel and Falk Kiefer Neuropsychopharmacology 2017 42: 367; 10.1038/npp.2016.159 Full Text Prospects for Medications to Reverse Causative Epigenetic Processes in Neuropsychiatry Disorders Moshe Szyf Neuropsychopharmacology 2017 42: 367-368; 10.1038/npp.2016.219 Full Text Ketamine Mechanism of Action: Separating the Wheat from the Chaff Todd D Gould, Panos Zanos and Carlos A Zarate, Jr Neuropsychopharmacology 2017 42: 368-369; 10.1038/npp.2016.210 Full Text The Direct and Indirect Pathways of the Nucleus Accumbens are not What You Think Yonatan M Kupchik and Peter W Kalivas Neuropsychopharmacology 2017 42: 369-370; 10.1038/npp.2016.160 Full Text Therapeutic Potential of Conjugated siRNAs for the Treatment of Major Depressive Disorder Francesc Artigas and Analia Bortolozzi Neuropsychopharmacology 2017 42: 371; 10.1038/npp.2016.182 Full Text Error Processing in Depressive States: A Translational Opportunity? Diego A Pizzagalli and William A Carlezon Neuropsychopharmacology 2017 42: 372; 10.1038/npp.2016.183 Full Text Imaging Adult Hippocampal Neurogenesis In Vivo Jeremy S Biane and Mazen A Kheirbek Neuropsychopharmacology 2017 42: 373; 10.1038/npp.2016.200 Full Text Emerging Epigenetic Therapies in Neuroscience: Focus on Bromodomain-Containing Drug Targets Claes Wahlestedt Neuropsychopharmacology 2017 42: 374; 10.1038/npp.2016.203 Full Text REM Sleep on It! Richard Boyce and Antoine Adamantidis Neuropsychopharmacology 2017 42: 375; 10.1038/npp.2016.227 Full Text The Neuroimmune Basis of Excessive Alcohol Consumption Jody Mayfield and R Adron Harris Neuropsychopharmacology 2017 42: 376; 10.1038/npp.2016.177 Full Text Oxytocin-Augmented Psychotherapy: Beware of Context René Hurlemann Neuropsychopharmacology 2017 42: 377; 10.1038/npp.2016.188 Full Text A Self-Generated Environmental Factor as a Potential Contributor to Atypical Early Social Communication in Autism Takefumi Kikusui and Noboru Hiroi Neuropsychopharmacology 2017 42: 378; 10.1038/npp.2016.225 Full Text Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.